Company intelligence / Profile preview

Anitoa Systems

Menlo Park, California, United Statesanitoa.com ↗

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

Anitoa Systems has commercialized portable real-time PCR instruments and nucleic acid test kits for rapid diagnosis of infectious diseases. Their products are CE-marked and FDA registered for research and clinical use. They have launched solutions for COVID variants (Omicron/Delta), monkeypox, dengue fever, swine flu in livestock, among others

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic device
Industry: Molecular Diagnostics

Partnerships

Stanford HospitalZhejiang Nanosystems InstituteFirst Affiliated Hospital of Zhejiang UniversityRuijing Hospital Shanghai

Beyond the preview

Go deeper on Anitoa Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anitoa Systems.

Explore the full profile